There are 2789 resources available
1753P - REarranged during Transfection [RET] gene fusion testing patterns for patients [pts] with papillary thyroid cancer [PTC] across five European countries
Presenter: Michael Kostikas
Session: ePoster Display
1754P - Current picture of Anaplastic Thyroid Cancer patients' care and meetable needs: A survey of 94 institutions from the EORTC Endocrine and Head and Neck Cancer Groups
Presenter: Laura Locati
Session: ePoster Display
1756TiP - Dabrafenib and trametinib combination as a neoadjuvant strategy in BRAF-positive anaplastic thyroid cancer (ANAPLAST-NEO)
Presenter: Yuliya Mikheeva
Session: ePoster Display
1762P - Association of clonal hematopoiesis of indeterminate potential with higher risk of disease progression
Presenter: Derek Klarin
Session: ePoster Display
1764P - A dose and time-dependent inhibitory effect of thymoquinone on inflammasome pathway in hormone receptor positive breast cancer: A novel personalized adjuvant therapy
Presenter: Sawsan Elgohary
Session: ePoster Display
1765P - The lack of KRAS variation and its therapeutic implication in MSI-H colorectal cancer with NTRK fusion
Presenter: Chenlu Zhang
Session: ePoster Display
1766P - Longitudinal alteration of cytokine profile in the peripheral blood and clinical response for neoadjuvant chemotherapy in triple-negative breast cancer patients (translational research of the JBCRG-22 trial)
Presenter: Kousuke Kawaguchi
Session: ePoster Display
1767P - Co-clinical PDX study of trastuzumab deruxtecan in HER2-positive uterine carcinosarcoma (STATICE trial, NCCH1615)
Presenter: Shigehiro Yagishita
Session: ePoster Display
1768P - Genome-wide association study to identify genetic markers predictive of early-onset capecitabine-induced toxicity
Presenter: Ik Shin Chin
Session: ePoster Display